Halozyme Therapeutics
HALO
$37.81
Share price
-0.55%
Change (1 day)
5.88%
Change (1 year)
Categories
Operating Margin for Halozyme Therapeutics (HALO)
Operating Margin as of April 2024 (TTM): 37.47%
According to Halozyme Therapeutics's latest financial reports and stock price the company's current Operating Margin is 37.47%. At the end of 2022 the company had an Operating Margin of 37.71%.
Operating Margin history for Halozyme Therapeutics from 2002 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 37.71% | -32.74% |
| 2021 | 56.06% | 16.02% |
| 2020 | 48.32% | -231.08% |
| 2019 | -36.86% | -29.84% |
| 2018 | -52.54% | -370.02% |
| 2017 | 19.46% | -128.02% |
| 2016 | -69.44% | 190.97% |
| 2015 | -23.86% | -73.71% |
| 2014 | -90.76% | -40.42% |
| 2013 | -152.33% | 20.4% |
| 2012 | -126.53% | 257.7% |
| 2011 | -35.37% | -90.95% |
| 2010 | -390.79% | -8.46% |
| 2009 | -426.88% | -23.2% |
| 2008 | -555.87% | -24.97% |
| 2007 | -740.89% | -53.32% |
| 2006 | -1,587.26% | -84.79% |
| 2005 | -10,435.88% | |
| 2003 | -307.69% | 318.93% |
| 2002 | -73.45% | -54.28% |
| 2001 | -160.63% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -38.94% | 🇺🇸 USA |
 Pfizer PFE | 34.61% | -7.63% | 🇺🇸 USA |
 Eli Lilly LLY | 24.66% | -34.19% | 🇺🇸 USA |
 Sanofi SNY | 18.21% | -51.40% | 🇫🇷 France |
 Baxter BAX | -19.01% | -150.73% | 🇺🇸 USA |
 MannKind Corp MNKD | -87.60% | -333.79% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.